发明公开
EP2881115A1 MEDICINE AGAINST GASTROESOPHAGEAL REFLUX DISEASE
审中-公开
ARZNEIMITTEL GEGENGASTROÖSOPHAGEALENREFLUX
- 专利标题: MEDICINE AGAINST GASTROESOPHAGEAL REFLUX DISEASE
- 专利标题(中): ARZNEIMITTEL GEGENGASTROÖSOPHAGEALENREFLUX
-
申请号: EP13825231.7申请日: 2013-07-30
-
公开(公告)号: EP2881115A1公开(公告)日: 2015-06-10
- 发明人: OKADA, Hiroki , KONEMURA, Takashi
- 申请人: ONO Pharmaceutical Co., Ltd.
- 申请人地址: 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 JP
- 专利权人: ONO Pharmaceutical Co., Ltd.
- 当前专利权人: ONO Pharmaceutical Co., Ltd.
- 当前专利权人地址: 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 JP
- 代理机构: Grünecker Patent- und Rechtsanwälte PartG mbB
- 优先权: JP2012169037 20120731; JP2012281959 20121226
- 国际公布: WO2014021306 20140206
- 主分类号: A61K31/426
- IPC分类号: A61K31/426 ; A61K31/4439 ; A61K31/444 ; A61K45/00 ; A61P1/04 ; A61P43/00
摘要:
The present invention provides an agent for preventing or relapse-preventing, treating or ameliorating gastroesophageal reflux disease, in which existing treatment is not effective.
4-[({6-[Isobutyl(1,3-thiazol-2-ylsulfonyl)amino]-2,3-dihydro-1H-inden-5-yl}oxy)methyl]-3-methyl benzoic acid, a salt thereof or a prodrug thereof is effective in the prevention or relapse prevention, treatment or amelioration of gastroesophageal reflux disease.
4-[({6-[Isobutyl(1,3-thiazol-2-ylsulfonyl)amino]-2,3-dihydro-1H-inden-5-yl}oxy)methyl]-3-methyl benzoic acid, a salt thereof or a prodrug thereof is effective in the prevention or relapse prevention, treatment or amelioration of gastroesophageal reflux disease.
信息查询
IPC分类: